Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||
Cash flow from continuing operating activities | -188.09%-11.21M | 12.72M | |||
Net income from continuing operations | -123.85%-2.24M | ---- | ---- | --9.38M | ---- |
Operating gains losses | 1,888.92%446.71K | ---- | ---- | ---24.97K | ---- |
Depreciation and amortization | 15.54%4.1M | ---- | ---- | --3.54M | ---- |
Deferred tax | 79.23%-46.31K | ---- | ---- | ---223.02K | ---- |
Other non cash items | ---- | ---- | ---- | --1 | ---- |
Change In working capital | -2,460.35%-13.5M | ---- | ---- | ---527.44K | ---- |
-Change in receivables | 214.30%1.73M | ---- | ---- | ---1.51M | ---- |
-Change in inventory | -216.10%-6.75M | ---- | ---- | ---2.13M | ---- |
-Change in prepaid assets | -271.66%-1.24M | ---- | ---- | ---332.39K | ---- |
-Change in payables and accrued expense | -203.84%-5.25M | ---- | ---- | --5.05M | ---- |
-Change in other current assets | 1.05%-1.56M | ---- | ---- | ---1.58M | ---- |
-Change in other current liabilities | -229.94%-565.6K | ---- | ---- | ---171.43K | ---- |
-Change in other working capital | -13.32%124.74K | ---- | ---- | --143.91K | ---- |
Cash from discontinued investing activities | |||||
Operating cash flow | -188.09%-11.21M | -256.24%-9.57M | --2.61M | --12.72M | --6.12M |
Investing cash flow | |||||
Cash flow from continuing investing activities | -371.51%-11.59M | 68.80%-342.24K | -10.58M | -2.46M | -1.1M |
Net PPE purchase and sale | -377.77%-11.59M | 67.73%-335.18K | ---10.58M | ---2.42M | ---1.04M |
Net intangibles purchase and sale | 79.04%-7.06K | 87.88%-7.06K | --0 | ---33.69K | ---58.28K |
Cash from discontinued investing activities | |||||
Investing cash flow | -371.51%-11.59M | 68.80%-342.24K | ---10.58M | ---2.46M | ---1.1M |
Financing cash flow | |||||
Cash flow from continuing financing activities | 392.00%11.3M | 9,889.06%8.33M | 2.98M | 2.3M | 83.39K |
Net issuance payments of debt | 443.55%14.02M | 1,992.10%7.64M | --3.67M | --2.58M | --365.07K |
Cash dividends paid | -863.97%-2.72M | --0 | --0 | ---281.68K | ---281.68K |
Cash from discontinued financing activities | |||||
Financing cash flow | 392.00%11.3M | 9,889.06%8.33M | --2.98M | --2.3M | --83.39K |
Net cash flow | |||||
Beginning cash position | 96.35%20.82M | -41.27%10.41M | --15.81M | --10.6M | --17.72M |
Current changes in cash | -191.52%-11.5M | -130.94%-1.58M | ---4.99M | --12.56M | --5.11M |
Effect of exchange rate changes | 99.11%-20.92K | 123.81%478.87K | ---402.23K | ---2.34M | ---2.01M |
End cash Position | -55.31%9.31M | -55.31%9.31M | --10.41M | --20.82M | --20.82M |
Free cash flow | -322.74%-22.8M | -296.88%-9.91M | ---7.97M | --10.24M | --5.03M |
Currency Unit | USD | USD | USD | USD | USD |